Recent developments

at Tullis and our portfolio companies

News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

April

5

electroCore Announces Exclusive License Agreement with Teijin for Japan Territory

Upon favorable regulatory and payor coverage decisions in Japan, the parties will enter into an...

30

Exagen Inc. Expands In-Network Access with Evolutions Healthcare Systems

AVISE® Lupus and AVISE® CTD tests included in agreement SAN DIEGO, March 30, 2022 (GLOBE NEWSWIRE)...

22

Exagen Inc. Expands In-Network Benefit with Additional 22.7 Million Lives

New partnership will bring total patients with in-network testing benefit to more than 90...

22

Neurolens Partners With The University Of Montreal’s Clinique Universitaire De La Vision

Joint projects will fuel Neurolens clinical foundation and future product innovations Coppell, Texas, March 22,...

22

Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results

Six Quarterly Records: AVISE® CTD Volume, Testing Revenue, Testing Gross Margin, Testing Gross Margin...

16

Exagen Announces New Rheumatoid Arthritis Scientific Advisory Board

SAN DIEGO, March 16, 2022 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions,...

10

electroCore Announces Fourth Quarter and Full Year 2021 Financial Results

Full year 2021 net sales of approximately $5.5 million increased 56% over $3.5 million for full year 2020...

9

electroCore Announces Changes to its Board of Directors

Julie Bruzzone Goldstein and Tricia Wilber to join the Board, adding significant marketing, media...

1

ATEC Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Highlights

Revenue growth of 68% for full year 2021, including organic revenue growth of 50%...

10

TriSalus Life Sciences Expands Clinical Executive Team and Scientific Advisory Boards

Additions will support company focus to overcome liver and pancreatic cancer treatment barriers and...

9

Data Presented at 2022 International Stroke Congress Suggests Role for Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Stroke

Clinical trial (n=69) suggests safety and feasibility of nVNS for the acute treatment of...

1

electroCore, Inc. Announces Completion of Enrollment in the TRANSIT Study of non-Invasive Vagus Nerve Stimulation (nVNS) in Post-Operative Ileus

Data on 97-patient, randomized, sham-controlled study to be presented at medical congress later this...

Recent developments

News

April

5

electroCore Announces Exclusive License Agreement with Teijin for Japan Territory

March

30

Exagen Inc. Expands In-Network Access with Evolutions Healthcare Systems

March

22

Exagen Inc. Expands In-Network Benefit with Additional 22.7 Million Lives

March

22

Neurolens Partners With The University Of Montreal’s Clinique Universitaire De La Vision

March

22

Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results

March

16

Exagen Announces New Rheumatoid Arthritis Scientific Advisory Board

March

10

electroCore Announces Fourth Quarter and Full Year 2021 Financial Results

March

9

electroCore Announces Changes to its Board of Directors

March

1

ATEC Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Highlights

February

10

TriSalus Life Sciences Expands Clinical Executive Team and Scientific Advisory Boards

February

9

Data Presented at 2022 International Stroke Congress Suggests Role for Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Stroke

February

1

electroCore, Inc. Announces Completion of Enrollment in the TRANSIT Study of non-Invasive Vagus Nerve Stimulation (nVNS) in Post-Operative Ileus